Simpson Thacher Represents Dealer Managers in Pfizer Exchange Offers and Consent Solicitations



Joseph H. Kaufman Joseph H. Kaufman
Jonathan E. Cantor Jonathan E. Cantor
Andrew J. Pagliughi Andrew J. Pagliughi

The Firm represented Citigroup Global Markets Inc. and Goldman, Sachs & Co., as dealer managers and solicitation agents in exchange offers and related consent solicitations by Pfizer Inc. (“Pfizer”), in which Pfizer (i) offered to exchange 6.05% Notes due 2017, 5.2% Notes due 2020, 5.8% Notes due 2023 and 5.6% Notes due 2040 (the “Hospira Notes”), issued by Hospira, Inc., a company recently acquired by Pfizer, for new 6.05% Notes due 2017, 5.2% Notes due 2020, 5.8% Notes due 2023 and 5.6% Notes due 2040 issued by Pfizer and (ii) solicited consents to amend the Hospira indenture governing the Hospira Notes and the Hospira Notes.

Pfizer is a research-based, global biopharmaceutical company. Pfizer’s global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products.

The Simpson Thacher team included Joe Kaufman, John Lobrano, Sung Bum Cho and Maria Monte (Capital Markets); Jonathan Cantor and Taylor Alexander (Tax); and Andrew Pagliughi (Blue Sky).

Team and Contacts

Joseph H. Kaufman

Joseph H. Kaufman

Of Counsel

Andrew J. Pagliughi

Andrew J. Pagliughi

Associate